发明名称 |
Bacterial glycolipid activation of CD1d-restricted NKT cells |
摘要 |
Disclosed are methods for activating an NKT cell, methods of stimulating an immune response in a subject, methods of improving vaccine efficacy, and methods of treating an infection. Also disclosed are methods of promoting tumor rejection, treating cancer, modulating autoimmunity and inhibiting allergen-induced hypersensitivity in subjects. The methods include contacting an NKT cell with a bacterial glycolipid complexed with a CD1 molecule to activate the NKT cell. The bacterial glycolipid may be derived from a member of the Class Alphaproteobacteria. |
申请公布号 |
ZA200706208(B) |
申请公布日期 |
2008.04.30 |
申请号 |
ZA20070006208 |
申请日期 |
2007.07.26 |
申请人 |
BRIGHAM YOUNG UNIVERSITY;THE SCRIPPS RESEARCH INSTITUTE;THE UNIVERSITY OF CHICAGO |
发明人 |
TEYTON, LUC;SAVAGE, PAUL;BENDELAC, ALBERT |
分类号 |
C12N;C12Q;G01N |
主分类号 |
C12N |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|